Opera Medica et Physiologica

Evaluation of the Effectiveness of Scaffolds Based on Hyaluronic Acid Glycidyl Methacrylate as a Possible Platform for Brain Treatment

Published ahead of print December 15, 2020; Printed December 17, 2020; OM&P 2020 Volume 7 Issue 4, pages 22-34; doi:10.24411/2500-2295-2020-10011

3D bioengineering constructs are currently a promising area of research in the regeneration of various tissues. In our work, several modifications of scaffolds based on hyaluronic acid glycidyl methacrylate are presented. Scaffolds have been tested for biocompatibility with nerve cells in an in vivo model of traumatic brain injury. Throughout the experiment, the neurological status of the animals was monitored, and at the end, a histological examination of the brain was carried out. It has been shown that scaffolds are non-toxic to nerve cells and reduce the development of neurological deficit in animals in the post-traumatic period. The possibility of using the scaffold with a lower biodegradation rate as a carrier of a therapeutic drug has also been demonstrated.